POLE2 and bladder transitional cell carcinoma: To further investigate the molecular characteristics of POLE2 in BLCA, we detected its transcript expression in five independent GEO datasets (GSE13507, GSE37851, GSE40335, GSE52519, and GSE65635) and protein expression in clinical samples using IHC assay.